ÂÜÀòÂÒÂ×

Carl-Johan Carling is a Senior Scientist at AstraZeneca since February 2016, specializing in oligonucleotide chemistry, lipid nanoparticle formulation for mRNA therapies, small molecule formulation, and medicinal chemistry. Previous roles include formulation and analysis in inhalation technology. Carl-Johan Carling served as a Postdoctoral Scholar at the University of California San Diego, focusing on advanced nanomaterials for healthcare applications. Academic qualifications include a Ph.D. in Organic Chemistry and Nanotechnology from Simon Fraser University, along with two M.Sc. degrees in Organic Chemistry from Lund University and Queen's University.